Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An 'N-of-1' Study of the Histamine H@ Antagonist, Famotidine in Levodopa-induced Dyskinesia in Parkinson's Disease

NCT01937078 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT01937078
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01937078 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An 'N-of-1' Study of the Histamine H@ Antagonist, Famotidine in Levodopa-induced Dyskinesia in Parkinson's Disease
Lead sponsor
University Health Network, Toronto
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2011
Completion date
March 31, 2014
Enrollment
7 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dyskinesia